These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23943886)

  • 1. Improving the relative dose intensity of systemic chemotherapy in a community-based outpatient cancer center.
    Vavra KL; Saadeh CE; Rosen AL; Uptigrove CE; Srkalovic G
    J Oncol Pract; 2013 Sep; 9(5):e203-11. PubMed ID: 23943886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne M; Crawford J; Dale DC; Culakova E; Lyman GH;
    Breast Cancer Res Treat; 2006 Dec; 100(3):255-62. PubMed ID: 16705366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting.
    Lyman GH; Dale DC; Tomita D; Whittaker S; Crawford J
    Breast Cancer Res Treat; 2013 Jun; 139(3):863-72. PubMed ID: 23771731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey.
    Sakai H; Katsumata N; Kadokura G
    BMC Cancer; 2015 Oct; 15():651. PubMed ID: 26438185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Poniewierski MS; Wolff D; Dale DC; Crawford J; Lyman GH
    Cancer; 2007 Oct; 110(7):1611-20. PubMed ID: 17705197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastim.
    Balducci L; Mo M; Abella E; Saven A
    Am J Clin Oncol; 2014 Dec; 37(6):603-10. PubMed ID: 25350463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices.
    Lyman GH; Dale DC; Crawford J
    J Clin Oncol; 2003 Dec; 21(24):4524-31. PubMed ID: 14673039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neutropenia on delivering planned chemotherapy for solid tumours.
    Khan S; Dhadda A; Fyfe D; Sundar S
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):19-25. PubMed ID: 18181887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is chemotherapy dose intensity adequate in breast cancer management in the Australian healthcare setting: a retrospective analysis.
    Bae S; Yeung Y; Ng S; Craike M; Livingston PM; Chirgwin J
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e54-62. PubMed ID: 22989364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.
    Denduluri N; Patt DA; Wang Y; Bhor M; Li X; Favret AM; Morrow PK; Barron RL; Asmar L; Saravanan S; Li Y; Garcia J; Lyman GH
    J Natl Compr Canc Netw; 2015 Nov; 13(11):1383-93. PubMed ID: 26553767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic.
    Sandy J; Della-Fiorentina S
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):365-72. PubMed ID: 23937317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of relative dose intensity and survival in patients with metastatic solid tumors.
    Havrilesky LJ; Reiner M; Morrow PK; Watson H; Crawford J
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):203-10. PubMed ID: 25459671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer.
    Cousin S; Le Rhun E; Mailliez A; Fournier C; Bonneterre J
    Bull Cancer; 2012; 99(7-8):75-80. PubMed ID: 22713627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice.
    Weycker D; Barron R; Edelsberg J; Kartashov A; Lyman GH
    Breast Cancer Res Treat; 2012 May; 133(1):301-10. PubMed ID: 22270932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
    Lyman GH; Dale DC; Friedberg J; Crawford J; Fisher RI
    J Clin Oncol; 2004 Nov; 22(21):4302-11. PubMed ID: 15381684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: an analysis of 1655 patients.
    Chan A; McGregor S; Liang W
    Breast; 2014 Oct; 23(5):676-82. PubMed ID: 25108452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy.
    Shayne M; Culakova E; Wolff D; Poniewierski MS; Dale DC; Crawford J; Lyman GH
    Cancer; 2009 Nov; 115(22):5319-28. PubMed ID: 19672945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
    Ariyoshi Y; Ogawa M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.